ACTIVEFINE Active Fine Chemicals Limited
Pharmaceuticals & Chemicals
Tk 4.6 as of 2026-11-12 14:04:22
Rank 256 of all scored
Data completeness 100%
Data completeness 100%
Override: Avoid. Operational status: Operation Shutdown.
Score breakdown
Consistency 58
Profitability 11
Solvency 81
Valuation 60
Weights: consistency 30%, profitability 30%, solvency 20%, valuation 20%; then risk flags add or subtract points. Full method
Why this score
Strengths
- Consistency Paid a dividend every year (5/5)
- Valuation Trades near book value (P/NAV 0.21x)
- Valuation Price is 38% below the Graham fair value (Tk 7.4)
Concerns
- Consistency EPS rose in only 1 of 4 years (erratic or cyclical)
- Profitability Average ROE only 7.83% (below 10%: capital not working hard)
- Profitability Net profit shrinking 53.49% a year
- Valuation P/E 41.82 is high (above 20)
Notes
- Solvency Debt/equity 0.6x (well managed)
Risk flags
- Category Z (poor/defaulting: gambling favourite, avoid for long-term)
- Small cap (< Tk 200 cr): most exposed to manipulation and volatility
- Low sponsor/director holding (12.04%): weak commitment
- Within 9.52% of its 52-week low: check WHY before treating it as cheap
Valuation
P/E
P/E audited
P/E current
P/B
NAV per share
EPS (last audited year)
Graham fair value
Margin of safety
52-week range
9.5% above the low, 43.2% below the high. Near the low is only interesting if profit is intact (see concerns above) and the fall has a temporary cause.
Quality and growth
ROE
ROE avg
ROE min
Profit CAGR
Profit YoY
Net profit
EPS up
Loss years (last ~5)
Dividends and safety
Div years
Dividend yield
Payout
Cash div
D/E
Loans/MCap
Size, liquidity and ownership
MCap
Free float
Daily turnover
Sponsor %
Inst. %
Public %
Foreign %
Shareholding
- Sponsor/director 12%
- Institution 21.1%
- Foreign 0.3%
- Public 66.6%
Audited history
| Year | EPS (Tk) | NAV/share | Net profit (cr) | Cash div % | Bonus % |
|---|---|---|---|---|---|
| 2018 | 3.46 | 24.45 | 55 | 0 | 25 |
| 2019 | 4.13 | 23.69 | 83 | 0 | 20 |
| 2020 | 2.97 | 22.28 | 71 | 2 | 0 |
| 2021 | 0.16 | 22.01 | 4 | 0.5 | 0 |
| 2022 | 0.11 | 22.07 | 3 | 0.3 | 0 |
Fiscal year ends June. EPS, NAV and profit are as audited by the company and published by DSE. Financials last fetched: 14/11/2026.
Shariah screen (partial)
Business screen and the debt ratio (loans / market cap 289%, limit 33%) are automated. Interest income (under 5% of revenue) and cash/investment ratios must be checked in the annual report.
Educational, not investment advice. Verify on DSE and StockNow before making any decision.